Hikma Pharmaceutical | HIK - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
Almirall 79.43 0.3 2025-12
argenx SE 35.53 3.41 2026-06
AstraZeneca 25.34 4.25 2026-06
Bayer 4.14 0.74 2026-06
Fresenius 11.44 4.91 2026-06
Genmab 16.04 1.05 2026-06
GlaxoSmithKline 10.63 4.24 2026-06
GRIFOLS 14.71 3.73 2026-06
Hikma Pharmaceutical 10.43 3.72 2025-12
Lakefront Biotherapeutics 2.68 0.14 2026-06
Lonza 34.34 2.58 2025-12
Merck 17.21 4.47 2026-06
Orion 17.23 1.3 2026-06
Recordati 22.75 5.09 2026-06
Roche Holding 16.48 0.39 2026-06
Sanofi 18.96 7.12 2026-06
UCB 29.7 5.52 2025-12